As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  4:15pm† Patel Tushar Bhikhubhai           SC 13D/A               3:170K Amneal Pharmaceuticals, Inc.      K&L Gates LLP/DC/FA      
  5/8/24  Amneal Pharmaceuticals, Inc.      10-Q        3/31/24   99:8.3M                                                            
  5/7/24  Amneal Pharmaceuticals, Inc.      8-K:5        5/2/24   10:211K                                   Workiva Inc Wde… FA01/FA 
  5/6/24  Yanai Shlomo                      4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/6/24  Patel Gautam                      4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/6/24  Nark Ted C                        4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/6/24  Kiely John                        4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/6/24  George Jeffrey P.                 4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/6/24  Buchi J Kevin                     4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/6/24  Autor Deborah M.                  4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/6/24  Alva Emily Peterson               4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/6/24  Meister Paul M                    4          Director²   1:5K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  5/3/24  Amneal Pharmaceuticals, Inc.      8-K:2,7,9    5/3/24   11:492K                                                            
 4/24/24  Fosun International Ltd.          SC 13G/A               1:57K  Amneal Pharmaceuticals, Inc.      Toppan Merrill/FA        
          Ambient Impact (HK) Ltd.³
 3/22/24  Amneal Pharmaceuticals, Inc.      DEFA14A                1:911K                                   Labrador Co./FA          
 3/22/24  Amneal Pharmaceuticals, Inc.      DEF 14A      5/2/24   11:7.3M                                   Labrador Co./FA          
 3/14/24  Amneal Pharmaceuticals, Inc.      10-K       12/31/23  160:18M                                                             
 3/14/24  Konidaris Tasos                   4          Officer²    1:7K   Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  3/6/24  Patel Chintu                      4          Dir.,Off.²  2:216K Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 
  3/6/24  Patel Chirag K.                   4          Dir.,Off.²  2:191K Amneal Pharmaceuticals, Inc.      Workiva Inc Wde… FA01/FA 

____________
†	The Filing’s time of SEC acceptance (U.S. Eastern Time).  The SEC’s Filings System is “open” Monday through Friday from 6am to 10pm ET. Because the SEC “closes” at 5:30pm ET, most subsequently-accepted Filings won’t be released to the public until sometime after 6am ET the next day.
¹	Filing/Form Types:  -K
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
	SC 13D	Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
³	Group Member:  A Registrant or non-Registrant party to this Filing made by a Group.